| ALCL | anaplastic large-cell lymphoma |
| BAG-1 | BCL-2 associated athanogene |
| Bcl-3 | B-cell lymphoma 3 |
| C/EBP | CCAAT enhancer-binding protein |
| EBV | Epstein–Barr virus |
| EGFR | epidermal growth factor receptor |
| EMSA | electrophoresis mobility shift assay |
| ERK | extracellular regulated kinase |
| HCC | hepatocellular carcinoma |
| HDAC1 | histone deacetylase 1 |
| HPV16 | human papilloma virus 16 |
| IFN | interferon |
| IKK | IκB kinase |
| IL | interleukin |
| IκB | inhibitor of kappa light polypeptide gene enhancer in B-cells |
| JAK-STAT | Janus kinase-Signal transducer and activator of transcription |
| KPC1 | Kip1 ubiquitination-promoting complex 1 |
| LPS | lipopolysaccharide |
| MEK | mitogen-activated protein kinase kinase |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
| NF-κB | nuclear factor of kappa light polypeptide gene enhancer in B-cells |
| NSCLC | non-small-cell lung carcinoma |
| PD-L1 | programmed death-ligand 1 |
| PTEN | phosphatase and tensin homolog |
| SCCHN | squamous cell carcinoma of the head and neck |
| STAT | signal transducer and activator of transcription |
| TAD | transcriptional activation domain |
| TIM-3 | T-cell immunoglobulin and mucin-domain containing-3 |
| TNFα | tumour necrosis factor α |
| TPL-2 | tumour progression locus 2 |